Docetaxel: all 1,319 studies that test it
Page 6 of 14. Open to participants first (111), then studies with results posted, then the rest; newest registration first within each.
- Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal CarcinomatosisTerminatedNCT04583488Phase 1
- Efficacy and Safety of Toripalimab Combined With Docetaxel or Nab-paclitaxel in Patients With Advanced Gastric CancerStatus unknownNCT04563975Phase 2
- Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DICCompletedNCT04547153Phase 2
- A Phase Ib Study With Pegylated Recombinant Human Endostatin in Advanced / Metastatic NSCLC or Other Solid TumorsStatus unknownNCT04413227Phase 1
- A Study Evaluating The Safety, Efficacy and Pharmacokinetics Of Ipatasertib In Combination With Atezolizumab And Docetaxel In Metastatic Castration-Resistant Prostate Cancer (mCRPC).TerminatedNCT04404140Phase 1
- Biweekly TPF Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of Head and NeckCompletedNCT04397341Phase 2
- Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate CancerCompletedNCT04381832Phase 1/2
- Trial Evaluating Adapted Chemotherapy in Patients With Squamous CarcinomaCompletedNCT04356170Phase 2
- Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric CancerCompletedNCT04354662Phase 2
- A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric CancerStatus unknownNCT04351867Phase 3
- Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 BlockadeActive, not recruitingNCT04340882Phase 2
- Trial of NanoDoce Intratumoral Injection in Renal Cell CarcinomaWithdrawnNCT04260360Phase 1
- Trial of Neoadjuvant Durvalumab Plus Docetaxel, Oxaliplatin, S-1 Followed by Surgery and Adjuvant Durvalumab Plus S-1 Chemotherapy in Potentially Resectable MMR Proficient Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT04221555Phase 2
- Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-CancerCompletedNCT04187898Phase 1
- SCT-I10A or Placebo Plus Docetaxel With Previously Treated Squamous Cell Non-small Cell Lung CancerTerminatedNCT04171284Phase 3
- Phase III Study of Toripalimab Versus Placebo Plus Chemotherapy in Resectable NSCLCCompletedNCT04158440Phase 3
- Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal CarcinomaActive, not recruitingNCT04156698Phase 2
- A Study to Evaluate Camrelizumab in Combination With Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage III Gastric CancerStatus unknownNCT04152889Phase 2
- A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and ChemotherapyWithdrawnNCT04151563Phase 1/2
- Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER)CompletedNCT04127019Phase 3
- Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the ExtremitiesTerminatedNCT04037527Phase 1
- KN035 in Combination With Trastuzumab and Docetaxel in HER2-positive Breast CancerStatus unknownNCT04034823Phase 2
- PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNAActive, not recruitingNCT04015622Phase 2
- Study of HL-085 Plus Docetaxel in Patients With KRAS Mutant NSCLCTerminatedNCT03990077Phase 1
- The Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy or Apatinib for Locally Advanced ESCCStatus unknownNCT03917966Phase 2
- A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast CancerStatus unknownNCT03863223Phase 3
- Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Chemotherapy in Patients With HER2 Positive Breast CancerStatus unknownNCT03847818Not applicable
- Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine CarcinomaCompletedNCT03837977Phase 2
- Docetaxel Combined With Carboplatin Plus Anlotinib as First Line Treatment in NSCLCStatus unknownNCT03799601Phase 4
- Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung CancerStatus unknownNCT03750916Phase 2
- Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate CancerCompletedNCT03737370Phase 1
- Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in HER2 Positive Breast Cancer Patients.CompletedNCT03735966Phase 2
- Anlotinib Combined With Docetaxel for Advanced Non-Small Cell Lung Cancer（ALTER-L034）Status unknownNCT03735264Phase 2
- Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal CarcinomaActive, not recruitingNCT03708822Phase 2
- Rh-Endostatin (Endostar®) Continuous Intravenous InfusionStatus unknownNCT03706703Phase 2
- Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLCStatus unknownNCT03703596Phase 2
- Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by EnzalutamideActive, not recruitingNCT03700099Phase 2
- Compare Neoadjuvant DOS Combined With Toripalimab Versus SOX Combined With Toripalimab in Locally Advanced Gastric AdenocarcinomaActive, not recruitingNCT03691454Phase 2/3
- Anlotinib Plus Docetaxel for the Treatment of EGFR/ALK/ROS1 Mutation-negative Advanced Nonsquamous NSCLCStatus unknownNCT03654027Phase 2
- Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal CancerStatus unknownNCT03649945Phase 2
- Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric CancerCompletedNCT03647969Phase 2
- Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung CancerStatus unknownNCT03624309Phase 2
- Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLCActive, not recruitingNCT03611738Phase 1
- mFLOT Chemotherapy as First-line Treatment in GCCompletedNCT03606928Phase 1/2
- Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell CarcinomaCompletedNCT03600831Phase 2/3
- Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory OsteosarcomaActive, not recruitingNCT03598595Phase 1/2
- A Study to Test Radium-223 With Docetaxel in Patients With Prostate CancerActive, not recruitingNCT03574571Phase 3
- Phase I Study of the Combination of Anlotinib With Pemetrexed or DocetaxelStatus unknownNCT03566576Not applicable
- Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by SurgeryActive, not recruitingNCT03493425Phase 2
- Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)Active, not recruitingNCT03448835Phase 2
- Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate CancerStatus unknownNCT03432780Phase 2
- Apatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC)Status unknownNCT03416231Phase 2
- Apatinib in Combination With Docetaxel for Patients With Advanced NSCLCStatus unknownNCT03411967Phase 2
- The EPIC Trial The Elderly Patient Individualized Chemotherapy TrialStatus unknownNCT03402048Phase 3
- A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly ChemotherapyCompletedNCT03371550Phase 2
- CPI-613 and Docetaxel in Treating Patients With Stage IIIB or IV Non-small Cell Lung CancerWithdrawnNCT03370159Phase 1/2
- 12 weekS Adjuvant dOcetaxel Plus trastuzumaB in Patients With Small, Node-negative, HER2-positive Breast cancER (SOBER)TerminatedNCT03367676Phase 2
- Mutation Scores and Differential Protein Evaluating Efficacy in Adjuvant Chemotherapy in HER2(-) Luminal B Breast CancerStatus unknownNCT03359694Phase 3
- Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant ChemotherapyStatus unknownNCT03349177Phase 2/3
- Toxicity & Pharmacokinetics of 2 & 3-weekly Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)WithdrawnNCT03343977Phase 1/2
- Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the BladderActive, not recruitingNCT03317158Phase 1/2
- Compare Apatinib Plus Chemotherapy Drug Versus Chemotherapy Drug as Second-line Treatment in NSCLCTerminatedNCT03256721Phase 2
- Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate CancerActive, not recruitingNCT03230734Phase 2
- QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint InhibitorsActive, not recruitingNCT03228667Phase 2
- Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast CancerCompletedNCT03221881Not applicable
- The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder RecurrenceStatus unknownNCT03209206Phase 2
- A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)Active, not recruitingNCT03178552Phase 2/3
- Different Chemotherapy Protocols Combined With Intensity Modulated Radiation Therapy in Patients With Locally Advanced Nasopharyngeal CarcinomaCompletedNCT03177174Not applicable
- The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric CancerStatus unknownNCT03154983Phase 2
- Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast CancerStatus unknownNCT03147963Phase 2
- Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric CancerStatus unknownNCT03137004Phase 2
- Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14Status unknownNCT03119857Phase 3
- MEDI5083 Alone and in Combination With Durvalumab, Tremelimumab, and/or Docetaxel.CompletedNCT03089645Phase 1
- A Clinical Trial of Apatinib Plus Docetaxel in Locally Advanced or Metastatic Gastric or GEJ AdenocarcinomaStatus unknownNCT03071042Phase 1
- Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by SurgeryActive, not recruitingNCT03070886Phase 2/3
- Clarify of Predictive Risk Factors of Chemotherapy-induced Liver InjuryStatus unknownNCT03069820Phase 4
- FOLFIRI Versus Docetaxel and Cisplatin as a Second-line Chemotherapy After Failure of First-line Chemotherapy in Advanced Gastric CancerCompletedNCT03067792Phase 3
- An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic AdenocarcinomaStatus unknownNCT03061643Phase 2
- Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, ClarithromycinTerminatedNCT03043989Phase 1
- A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection for Patients With Breast CancerCompletedNCT03017404Not applicable
- PHASE III RANDOMISED TRIAL to EVALUATE FOLFOX with or WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY for LOCALLY ADVANCED or METASTATIC OESOPHAGO-GASTRIC CARCINOMACompletedNCT03006432Phase 3
- Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC PatientsStatus unknownNCT03002064Phase 3
- Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell CarcinomaTerminatedNCT02997332Phase 1
- Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral TongueStatus unknownNCT02985255Phase 2
- Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast CancerCompletedNCT02980965Phase 3
- Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell CarcinomaStatus unknownNCT02969473Phase 2
- Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell CarcinomaCompletedNCT02964455Phase 1
- S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast CancerStatus unknownNCT02947061Phase 2
- Multicentric Randomised Trial for Resectable Gastric CancerActive, not recruitingNCT02931890Phase 2
- Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity CancerCompletedNCT02923258Phase 2/3
- Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.CompletedNCT02922777Phase 1
- A Study of RGX-104 in Patients With Advanced Lung & Endometrial CancerCompletedNCT02922764Phase 1
- Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland TumorsCompletedNCT02921984Phase 1
- Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPCCompletedNCT02913196Phase 1
- An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation StudyStatus unknownNCT02884479Phase 1/2
- DA Versus DAC as Postoperative Adjuvant Treatment for Early-stage Breast CancerCompletedNCT02838225Phase 2
- A Study of Ramucirumab (LY3009806) in Combination With Weekly Docetaxel in Participants With Stage IV Non-Small Cell Lung CancerWithdrawnNCT02831491Phase 2
- Docetaxel Followed by Provenge in Metastatic Prostate CancerWithdrawnNCT02793765Phase 2
- Provenge Followed by Docetaxel in Castration-Resistant Prostate CancerWithdrawnNCT02793219Phase 2
- A Study of Pemetrexed Plus Cisplatin With Concurrent Radiation Therapy Followed by Docetaxel Consolidation in Patients With Inoperable Squamous Cell Lung CancerStatus unknownNCT02787473Phase 2